secwatch.observer — SEC 8-K summary
======================================

Issuer:     Corbus Pharmaceuticals Holdings, Inc. (CRBP)
CIK:        0001595097
Form:       8-K
Filed at:   2024-02-06T23:59:59+00:00
Accession:  0000950170-24-011733
Event type: leadership
Sentiment:  negative
Materiality: 0.40
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Corbus Pharmaceuticals CSO Rachael Brake resigns effective Feb 19, 2024
-----------------------------------------------------------------------

- Chief Scientific Officer Rachael Brake submitted resignation on Feb 2, 2024.
- Resignation effective February 19, 2024.
- No replacement or reason for departure disclosed.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1595097/000095017024011733/0000950170-24-011733-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1595097/000095017024011733/crbp-20240202.htm
  HTML page:      https://secwatch.observer/filing/0000950170-24-011733

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer